Cancer Complementary and alternative medicine Medicine Pseudoscience Quackery Skepticism/critical thinking

If Rigvir is effective “virotherapy” for cancer, why are quack clinics selling it and quackery promoters like Ty Bollinger promoting it?

Last week, I wrote about Rigvir, a “virotherapy” promoted by the International Virotherapy Center (IVC) in Latvia, which did not like what I had to say. When a representative called me to task for referring to the marketing of Rigvir using patient testimonials as irresponsbile, it prompted me to look at how Ty Bollinger’s The Truth About Cancer series promoted Rigvir through patient testimonials and how the IVC itself uses such testimonials. The word “irresponsible” doesn’t even begin to cover it.

Cancer Clinical trials Medicine Pseudoscience Quackery Skepticism/critical thinking

Rigvir: A cancer "cure" imported from Latvia that cancer patients should avoid

Recently, the Hope4Cancer Institute, a quack clinic in Mexico has added a treatment known as Rigvir to its other offerings. But what is Rigvir? It turns out that it’s an import from Latvia with a mysterious history. Its proponents claim that it targets cancer specifically. Unfortunately, there is a profound paucity of evidence for its efficacy. The story of Rigvir is the story of an unproven treatment that, because of its origin in a small country, has flown mostly under the radar. Until now, that is.

Cancer Complementary and alternative medicine Medicine Quackery

Cutting, poisoning, and burning naturally

Not too long ago, a reader asked me about black salve, and then not too long later I saw a commenter mention black salve. It occurs to me that, in all the years I’ve been doing this blog and my other blog, I don’t think I’ve ever actually written about black salve, except in passing. […]

Bioethics Cancer Clinical trials Medicine Science

Balancing scientific rigor versus patient good in clinical trials

A critical aspect of both evidence-based medicine (EBM) and science-based medicine (SBM) is the randomized clinical trial. Ideally, particularly for conditions with a large subjective component in symptomatology, the trial should be randomized, double-blind, and placebo-controlled. As Kimball Atwood pointed out just last week (me too), in EBM, scientific prior probability tends to be discounted […]